USPTO serial 86983080
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
Icahn School of Medicine at Mount Sinai
New York, NY, US
Other trademarks owned by Icahn School of Medicine at Mount Sinai
NEW YORK, NY, US
NEW YORK, NY, US
Stamford, CT, US
Icahn School of Medicine at Mount Sinai
New York, NY, US
Other trademarks owned by Icahn School of Medicine at Mount Sinai
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa C. Pavento
Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree Street NESuite 1300Atlanta, GA 30309| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins ] | SECTION 8 - CANCELLED | May 1, 2017 |
| 005 | [ Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, namely, cancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins ] | SECTION 8 - CANCELLED | May 1, 2017 |
| 035 | [ Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business information, namely, commercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management ] | SECTION 8 - CANCELLED | May 1, 2017 |
| 042 | [ Medical and scientific research in the field of biologic testing and interpretation, diagnosis, treatment, and health maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; ] providing information in the field of disease classification for use in connection with diagnostic testing [; development of scientific research and technology for purposes of disease diagnosis, preventative health care, health monitoring, and personalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosis, treatment, and health maintenance information; providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; scientific and medical research, namely, identifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins ] | ACTIVE | May 1, 2017 |
| 044 | Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes [; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testing, namely, identifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins ] | ACTIVE | May 1, 2017 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 22, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 1, 2026 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Jun 1, 2026 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| May 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jan 30, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jan 30, 2025 | PRAN | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | — |
| Jan 30, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 28, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 28, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 28, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 28, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 28, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 7, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Nov 8, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 7, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 10, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 10, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 7, 2018 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 7, 2018 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Dec 27, 2017 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Dec 27, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 27, 2017 | FAXX | FAX RECEIVED | — |
| Nov 20, 2017 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 7, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 30, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 29, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 13, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 13, 2017 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Sep 11, 2017 | IUAF | USE AMENDMENT FILED | — |
| Sep 11, 2017 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 11, 2017 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Sep 11, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 30, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 17, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 15, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 15, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 15, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 30, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 29, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 28, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 20, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 20, 2016 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 20, 2016 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Oct 20, 2016 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 20, 2016 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 17, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 17, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 15, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 15, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 19, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 19, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jun 15, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2015 | NWAP | NEW APPLICATION ENTERED | — |